Record High: 8.3% of UK Adults Use E-cigarettes

Aug.29.2022
Record High: 8.3% of UK Adults Use E-cigarettes
E-cigarette use in the UK hits record levels, with an estimated 4.3 million active users, according to a new report.

According to a new report from PA, the use of electronic cigarettes in the UK has reached a record high.


A new report states that electronic cigarette usage in the UK has reached record levels, with an estimated 4.3 million active users.


According to data shared exclusively with the PA news agency, 8.3% of adults in England, Wales, and Scotland use electronic cigarettes.


Just 10 years ago, this number was at 1.7% - equivalent to around 800,000 people.


Over the past decade, we have witnessed a revolution in the world of electronic cigarettes, according to Hazel Cheeseman, Vice President of ASH.


The Action on Smoking and Health (ASH) reports that there has been an "e-cigarette revolution" over the past decade.


Out of the current 4.3 million e-cigarette users, approximately 2.4 million are former smokers, 1.5 million are current smokers, and 350,000 have never smoked before.


Data also shows that the percentage of electronic cigarette users who have never smoked before has increased from 4.9% last year to 8.1% this year.


According to the latest ASH Smoke-free GB survey, 8.3% of adults in England, Wales, and Scotland use e-cigarettes, marking the highest level ever recorded.


The author of the report stated that the figure is at its "highest historical level.


By 2022, 35% of electronic cigarette users also smoke conventional cigarettes, and these individuals are sometimes referred to as "dual users.


However, within this group, individuals who vape electronic cigarettes daily tend to smoke less than those who do not vape frequently.


A report based on a survey conducted by YouGov, of over 13,000 adults from various regions of the United Kingdom, found that 28 percent of current smokers have never tried e-cigarettes. Of those individuals, 10 percent expressed concerns about the safety of e-cigarettes.


One third of adults believe that e-cigarettes are more harmful or equally harmful as smoking.


One-fifth of former smokers claim they have used electronic cigarettes to quit smoking.


More than half (56%) of former smokers say they have been using e-cigarettes for over three years.


According to reports from electronic cigarette users, the main reason they use electronic cigarettes is to quit smoking and prevent themselves from relapsing. 14% of users stated that they use electronic cigarettes simply because they enjoy them.


Most e-cigarette users report using refillable systems, but reports indicate an increase in the use of disposable e-cigarettes - from 2.3% of users in 2021 to 15% this year.


The author contends that young people are driving the rise of disposable e-cigarettes, with 48% of e-cigarette users aged 18 to 24 opting for this type of device.


They found that the most popular flavor is fruit, followed by mint.


In the past decade, we have witnessed an electronic cigarette revolution," said Hazel Cheeseman, Deputy CEO of ASH.


Currently, the number of e-cigarette users has increased five-fold since 2012, with millions of people using it as part of their attempt to quit smoking.


However, they are not suitable for everyone. Of those who have tried them, less than half have stopped using them, and 28% have not even tried them.


The government has stated that the "e-cigarette revolution" will assist them in achieving their ambitious goal of establishing a smoke-free nation by the year 2030. However, this alone is not sufficient, and a comprehensive plan is needed to aid all smokers.


Earlier this year, a report from ASH concluded that the proportion of children vaping is on the rise, with many citing social media sites like TikTok as an influence.


Although it is illegal to sell electronic cigarettes to those under the age of 18, the percentage of children aged 11 to 17 who use electronic cigarettes has risen from 4% in 2020 to 7% in 2022.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS and the company cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the translator's proficiency, the translated article may not fully express the original meaning. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues and stances.


The ownership of the compiled information belongs to the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Complete abstinence is not always the goal of addiction treatment under a harm-reduction approach, Japanese psychiatrist Tomohiro Shirasaka told 2Firsts in Manila. In the interview, he discussed patients' quality of life, Japan's shift towards heated tobacco products, and the challenges of quitting smoking for people with mental illness. Drawing on addiction treatment work in the Philippines, he advocated support rather than punishment and questioned whether fear-based health warnings effectively address the reasons people continue smoking.
Nov.10
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Product | OXVA Introduces XLIM PRO 4 With Liquid-Level Anti-Burn Technology and Dedicated Pods
Vaping brand OXVA introduced the XLIM PRO 4 refillable pod system in October 2026, featuring Anti-Burn Tech (ABT) based on smart e-liquid-level detection. The system can issue refill alerts and stop power output when e-liquid levels become too low. ABT requires the XLIM PRO 4 device and a dedicated XLIM ABT cartridge. Standard XLIM pods remain compatible but do not support ABT protection. OXVA previously introduced temperature-based anti-burn technology in the XLIM Pro 2 DNA, developed with Evolv. The new device features a 1,800mAh battery, 5–30W output and a 0.98-inch HD color screen. OXVA's official store lists the device at $37.90 and dedicated ABT replacement cartridges at $12.99. Independent testing confirmed the low-liquid protection response but recorded varying cartridge lifespans.
product
Oct.30
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Global PLC (NASDAQ: AIIR), a producer of flavored shisha tobacco and next-generation nicotine products, reported an 11.1% increase in third-quarter 2026 revenue to $99.8 million and a 7.7% rise in adjusted EBITDA to $30.9 million. Revenue for the first nine months increased 6.0% to $306.7 million, but the company posted a $74.2 million net loss, affected by listing-related expenses and other costs. Its New Growth Categories (NGC) business generated $2.1 million in nine-month revenue and an adjusted EBITDA loss of $10.8 million. AIR maintained its 2026 revenue growth guidance of 4%–6%, while lowering its capital expenditure outlook and raising its year-end leverage forecast from approximately 2.1 times to 2.5 times. The company has submitted a U.S. PMTA for its Crown Switch pod vape, with future contributions from new products dependent on regulatory progress and commercialization.
Capital Markets
Nov.13